CWM
INFI

CIBC World Markets’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

CIBC World Markets’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-21,481
Closed -$300K – 214
2015
Q1 		$300K Buy
+21,481
New +$328K 0.02% 68

Other funds holding INFI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CIBC World Markets's INFI Position: Q2 2015 in Review

CIBC World Markets sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2015, closing a stake of 21,481 shares — an estimated $300K sold.

CIBC World Markets first reported a position in INFI in Q1 2015 and held it in 1 quarter. The position peaked at $300K in Q1 2015. 137 funds tracked by Wall St. Rank hold INFI as of Q2 2015.

  • CIBC World Markets reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • CIBC World Markets sold 21,481 Infinity Pharmaceuticals, Inc. shares in Q2 2015, an estimated $300K.
  • CIBC World Markets first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • CIBC World Markets's Infinity Pharmaceuticals, Inc. position peaked at $300K in Q1 2015.
  • 137 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2015.

Based on CIBC World Markets's 13F filing for Q2 2015, filed 13 Aug 2015.